Back to search

Cornell University

Studying Emerging Zoonotic Viruses: from Pathogenicity Characterization to the Development of Vaccines and Therapeutics in Animal Models

Abstract

dc:description.abstract

Emerging zoonotic viruses pose a critical challenge to global public health due to their capacity to incite pandemics and overwhelm healthcare systems. This thesis focuses on understanding viral pathogenicity and developing innovative therapeutic and preventive strategies. Utilizing transgenic animal models, we explored the dynamics of pathogenicity among SARS-CoV-2 variants and expanded our scope to other high-priority zoonotic viruses, including Nipah, Hendra, and Ebola. In-depth studies of SARS-CoV-2 revealed distinct pathogenic mechanisms among Omicron subvariants BA.1, BA.4 and BA.5. While BA.1and BA.4 exhibited limited pathology, BA.5 demonstrated significantly higher virulence, characterized by severe respiratory pathology, cytokine dysregulation, and age-dependent lethality in K18-hACE2 transgenic mice. A key finding was the role of non-structural protein 1 (NSP1) in modulating host immune responses. A triple amino acid deletion (KSF) in NSP1, observed in BA.4 but absent in BA.5, was identified as a determinant of reduced virulence. Recombinant BA.5 expressing BA.4 NSP1 displayed attenuated pathogenicity, highlighting NSP1 as a potential target for therapeutic intervention. Beyond SARS-CoV-2, the development of broad-spectrum antivirals (BSAs) and multivalent vaccines emerged as pivotal strategies to combat a range of viral threats. We identified synthetic carbohydrate receptors (SCRs) as potent BSAs, demonstrating efficacy across six viral families, including Coronaviridae, Paramyxoviridae, and Filoviridae. SCR005 and SCR007 exhibited robust antiviral activity with minimal toxicity, targeting conserved N-glycans on viral glycoproteins to prevent host cell entry. In parallel, we designed a multivalent vesicular stomatitis virus (VSV)-based vaccine platform incorporating glycoproteins from Nipah, Hendra, and Ebola viruses. This vaccine elicited durable immune responses and provided complete protection in swine and rodent models. The incorporation of trehalose-based adjuvants further enhanced immunogenicity while maintaining safety profiles. This research advances our understanding of viral pathogenesis and offers innovative approaches to therapeutic and vaccine development. By elucidating molecular determinants of virulence and leveraging conserved viral features, we lay the groundwork for broad-spectrum solutions to current and future zoonotic threats. These findings hold significant promise for enhancing global preparedness against pandemics.

Degree

thesis:*
Name thesis:degree_name
Ph. D., Microbiology
Level thesis:degree_level
Doctor of Philosophy
Discipline thesis:degree_discipline
Microbiology
Grantor
Cornell University
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Ezzatpour, Shahrzad
Chair dc:contributor.chair
  • Aguilar-Carreno, Hector
Committee members dc:contributor.committeemember
  • Leifer, Cynthia
  • Whittaker, Gary

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*
Dc Identifier Bibid
16938309
Dc Identifier Other
ProQuest Submission ID: 14841
ProQuest Publication ID: 31841783

Chain of custody

source
Harvested from
Cornell University
Base URL
ecommons.cornell.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Ezzatpour, Shahrzad. Studying Emerging Zoonotic Viruses: from Pathogenicity Characterization to the Development of Vaccines and Therapeutics in Animal Models. Doctor of Philosophy thesis, Cornell University, 2025. https://hdl.handle.net/1813/117556